May 9, 2016 7:00 am EDT VolitionRx Schedules First Quarter 2016 Earnings Conference Call and Business Update for Friday, May 13, 2016 at 8:30am ET
Apr 20, 2016 9:00 am EDT VolitionRx Announces Study Results Showing NuQ® Blood Test Detects Prostate Cancer Early with Significantly Higher Accuracy than PSA Test
Apr 14, 2016 7:00 am EDT VolitionRx Appoints Louise Day as Chief Marketing and Communications Officer
Apr 8, 2016 7:00 am EDT VolitionRx to Present at AACR Annual Meeting and Announce First Results from Prostate Cancer Study
Apr 7, 2016 7:08 am EDT VolitionRx Announces CE Marks for Two NuQ® Blood Assays for Detection of Colorectal Cancer
Mar 23, 2016 11:30 am EDT VolitionRx Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full
